Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 945

1.

Ponatinib (AP24534) inhibits MEKK3-KLF signaling and prevents formation and progression of cerebral cavernous malformations.

Choi JP, Wang R, Yang X, Wang X, Wang L, Ting KK, Foley M, Cogger V, Yang Z, Liu F, Han Z, Liu R, Baell J, Zheng X.

Sci Adv. 2018 Nov 7;4(11):eaau0731. doi: 10.1126/sciadv.aau0731. eCollection 2018 Nov.

2.

Routinely Performed Serial Follow-Up Imaging in Asymptomatic Patients With Multiple Cerebral Cavernous Malformations Has No Influence on Surgical Decision Making.

Velz J, Stienen MN, Neidert MC, Yang Y, Regli L, Bozinov O.

Front Neurol. 2018 Oct 11;9:848. doi: 10.3389/fneur.2018.00848. eCollection 2018.

3.

Cerebral Cavernous Malformations Develop Through Clonal Expansion of Mutant Endothelial Cells.

Detter MR, Snellings DA, Marchuk DA.

Circ Res. 2018 Oct 26;123(10):1143-1151. doi: 10.1161/CIRCRESAHA.118.313970.

PMID:
30359189
4.

Intradural Extramedullary Thoracic Cavernoma in a Man with Familial Multiple Cavernomas.

Ziechmann R, Zyck S, Krishnamurthy S, Galgano M.

Cureus. 2018 Aug 7;10(8):e3115. doi: 10.7759/cureus.3115.

5.

The cerebral cavernous malformation disease causing gene KRIT1 participates in intestinal epithelial barrier maintenance and regulation.

Wang Y, Li Y, Zou J, Polster SP, Lightle R, Moore T, Dimaano M, He TC, Weber CR, Awad IA, Shen L.

FASEB J. 2018 Sep 25:fj201800343R. doi: 10.1096/fj.201800343R. [Epub ahead of print]

PMID:
30252535
6.

A single-center study on 140 patients with cerebral cavernous malformations: 28 new pathogenic variants and functional characterization of a PDCD10 large deletion.

Nardella G, Visci G, Guarnieri V, Castellana S, Biagini T, Bisceglia L, Palumbo O, Trivisano M, Vaira C, Scerrati M, Debrasi D, D'Angelo V, Carella M, Merla G, Mazza T, Castori M, D'Agruma L, Fusco C.

Hum Mutat. 2018 Aug 30. doi: 10.1002/humu.23629. [Epub ahead of print]

PMID:
30161288
7.

Hippocampal Transection Plus Tumor Resection as a Novel Surgical Treatment for Temporal Lobe Epilepsy Associated with Cerebral Cavernous Malformations.

Ishida W, Morino M, Matsumoto T, Casaos J, Ramhmdani S, Lo SL.

World Neurosurg. 2018 Nov;119:e209-e215. doi: 10.1016/j.wneu.2018.07.108. Epub 2018 Jul 29.

PMID:
30064030
8.

Contemporary radiosurgery of cerebral cavernous malformations: Part 2. Treatment outcome for hemispheric lesions.

Nagy G, Stokes SS, Erőss LG, Bhattacharyya D, Yianni J, Rowe JG, Kemeny AA, Radatz MWR.

J Neurosurg. 2018 Jul 27:1-9. doi: 10.3171/2018.2.JNS171267. [Epub ahead of print]

PMID:
30052157
9.

Contemporary radiosurgery of cerebral cavernous malformations: Part 1. Treatment outcome for critically located hemorrhagic lesions.

Nagy G, Burkitt W, Stokes SS, Bhattacharyya D, Yianni J, Rowe JG, Kemeny AA, Radatz MWR.

J Neurosurg. 2018 Jul 27:1-9. doi: 10.3171/2017.5.JNS17776. [Epub ahead of print]

PMID:
30052154
10.

Intensive, functional training leads to optimal outcomes in a young woman post brain stem hemorrhage due to cerebral cavernous malformation.

Thompson K, Mattern-Baxter K.

Physiother Theory Pract. 2018 Jul 6:1-12. doi: 10.1080/09593985.2018.1493166. [Epub ahead of print]

PMID:
29979899
11.

Phenotypic characterization of murine models of cerebral cavernous malformations.

Zeineddine HA, Girard R, Saadat L, Shen L, Lightle R, Moore T, Cao Y, Hobson N, Shenkar R, Avner K, Chaudager K, Koskimäki J, Polster SP, Fam MD, Shi C, Lopez-Ramirez MA, Tang AT, Gallione C, Kahn ML, Ginsberg M, Marchuk DA, Awad IA.

Lab Invest. 2018 Jun 26. doi: 10.1038/s41374-018-0030-y. [Epub ahead of print]

PMID:
29946133
12.

[The transpalpebral keyhole approach in surgery of orbital cavernomas: a case report and literature review].

Dzhindzhikhadze RS, Dreval' ON, Lazarev VA, Polyakov AV.

Zh Vopr Neirokhir Im N N Burdenko. 2018;82(3):73-80. doi: 10.17116/neiro201882373. Russian.

PMID:
29927428
13.

Bleeding risk of cerebral cavernous malformations in patients on β-blocker medication: a cohort study.

Goldberg J, Jaeggi C, Schoeni D, Mordasini P, Raabe A, Bervini D.

J Neurosurg. 2018 Jun 15:1-6. doi: 10.3171/2017.12.JNS172404. [Epub ahead of print]

PMID:
29905510
14.

A Novel PKD1 Mutation Associated With Autosomal Dominant Kidney Disease and Cerebral Cavernous Malformation.

Thomas C, Zühlsdorf A, Hörtnagel K, Mulahasanovic L, Grauer OM, Kümpers P, Wiendl H, Meuth SG.

Front Neurol. 2018 May 25;9:383. doi: 10.3389/fneur.2018.00383. eCollection 2018.

15.

Antithrombotic medication and bleeding risk in patients with cerebral cavernous malformations: a cohort study.

Bervini D, Jaeggi C, Mordasini P, Schucht P, Raabe A.

J Neurosurg. 2018 Jun 8:1-9. doi: 10.3171/2018.1.JNS172547. [Epub ahead of print]

PMID:
29882707
16.

[Cerebral cavernous malformation 3 gene deficiency promotes early changes in Alzheimer disease-like lesions induced by low lead exposure].

Wu S, Xia D, Liu HX, Zhao HP, Wang XH, Gao YF, Zhao ZQ, Xiao C, Xing XM, He Y.

Zhonghua Yu Fang Yi Xue Za Zhi. 2018 May 6;52(5):545-551. doi: 10.3760/cma.j.issn.0253-9624.2018.05.015. Chinese.

PMID:
29747348
17.

Plasma Biomarkers of Inflammation and Angiogenesis Predict Cerebral Cavernous Malformation Symptomatic Hemorrhage or Lesional Growth.

Girard R, Zeineddine HA, Koskimäki J, Fam MD, Cao Y, Shi C, Moore T, Lightle R, Stadnik A, Chaudagar K, Polster S, Shenkar R, Duggan R, Leclerc D, Whitehead KJ, Li DY, Awad IA.

Circ Res. 2018 Jun 8;122(12):1716-1721. doi: 10.1161/CIRCRESAHA.118.312680. Epub 2018 May 2.

PMID:
29720384
18.

Cerebral Cavernous Malformations: An Update on Prevalence, Molecular Genetic Analyses, and Genetic Counselling.

Spiegler S, Rath M, Paperlein C, Felbor U.

Mol Syndromol. 2018 Feb;9(2):60-69. doi: 10.1159/000486292. Epub 2018 Jan 25. Review.

19.

Radiotherapy induced cavernomas in adult cancer patients.

Cacho-Díaz B, Salmerón-Moreno K, Lorenzana-Mendoza N, Reyes A, Valdés-Ferrer SI, Gómez-Ahumada G, Reyes-Soto G, Herrera-Gómez Á.

Radiother Oncol. 2018 May;127(2):287-291. doi: 10.1016/j.radonc.2018.02.026. Epub 2018 Mar 19.

PMID:
29566995
20.

Transient Focal Magnetic Resonance Imaging Abnormalities After Status Epilepticus Showed 11C-Methionine Uptake with Positron Emission Tomography in a Patient with Cerebral Cavernous Malformation.

Ishiguro T, Nitta M, Komori T, Maruyama T, Muragaki Y, Kawamata T.

World Neurosurg. 2018 Jun;114:43-46. doi: 10.1016/j.wneu.2018.03.020. Epub 2018 Mar 10.

PMID:
29530707

Supplemental Content

Loading ...
Support Center